A new pacemaker algorithm for the treatment of atrial fibrillation: Results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT)

Journal of the American College of Cardiology

Volumn 42, Issue 4, 2003, Pages 627-633

  Carlson, Mark D ^a,k   Ip, John ^b   Messenger, John ^c   Beau, Scott ^d   Kalbfleisch, Steven ^e   Gervais, Pierre ^f   Cameron, Douglas A ^g   Duran, Aurelio ^h   Val Mejias, Jesus ⁱ   Mackall, Judith ^a   Gold, Michael ^j  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Thoracic Cardiovascular Institute   (United States)

^c LONG BEACH MEMORIAL MEDICAL CENTER   (United States)

^d ARKANSAS HEART HOSPITAL   (United States)

^e MidOhio Cardiology and Vascular Consultants   (United States)

^f CH St Joseph   (Canada)

^g TORONTO GENERAL HOSPITAL   (Canada)

^h Orlando Heart Center   (United States)

ⁱ St Francis ICT   (United States)

^j MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^k UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT;

ADULT; AGED; ALGORITHM; ARTICLE; ARTIFICIAL HEART PACEMAKER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART RHYTHM; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SAFETY; SCORING SYSTEM; SICK SINUS SYNDROME; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

EID: 0041730635     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(03)00780-0     Document Type: Article

References (21)

1. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults. National implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. JAMA 2001;2370-5.
2. Roy D, Talajic M, Dorian P, et al. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med 2000;342:913-20.
3. Andersen HR, Nielsen JC, Thomsen PE, et al. Long-term follow-up of patients from a randomized trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet 1997;350:1210-6.
4. Skanes AC, Krahn AD, Yee R, et al., for the CTOPP Investigators. Progression to chronic atrial fibrillation after pacing: the Canadian Trial of Physiologic Pacing. J Am Coll Cardiol 2001;38:167-72.
5. Gregoratos G, Cheitlin MD, Conill A, et al. ACC/AHA Guidelines for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). J Am Coll Cardiol 1998;31:1175-209.
6. Hall D. Zero-inflated Poisson and binomial regression with random effects: a case study. Biometrics 2000;56:1030-9.
7. Sasaki Y, Shimotori M, Akahane K, et al. Long-term follow-up of patients with sick sinus syndrome: a comparison of clinical aspects among unpaced, ventricular inhibited paced, and physiologically paced groups. Pacing Clin Electrophysiol 1988;11:1575-83.
8. Stangl K, Seitz K, Wirtzfeld A, Alt E, Blomer H. Differences between atrial single chamber pacing (AAI) and ventricular single chamber pacing (VVI) with respect to prognosis and antiarrhythmia effect in patients with sick sinus syndrome. Pacing Clin Electrophysiol 1990;13:2080-5.
9. Feuer JM, Shandling AH, Messenger JC. Influence of cardiac pacing mode on the long-term development of atrial fibrillation. Am J Cardiol 1989;64:1376-9.
10. Hennelson AB, Parsonnet V, Bernstein AD, Bonavita GJ. Deleterious effects of long-term single-chamber ventricular pacing in patients with sick sinus syndrome: the hidden benefits of dual-chamber pacing. J Am Coll Cardiol 1992;19:1542-9.
11. Ragonese P, Drago F, Guccione P, Santilli A, Silvertti MS, Agostino DA. Permanent overdrive atrial pacing in the chronic management of recurrent postoperative atrial reentrant tachycardia in patients with complex congenital heart disease. Pacing Clin Electrophysiol 1997;20:2917-23.
12. Stabile G, Seantore G, De Simone A, et al. Determinants of efficacy of atrial pacing in preventing atrial fibrillation recurrences. J Cardiovasc Electrophysiol 1999;10:2-9.
13. Garrigue S, Barold SS, Cazeau S, et al. Prevention of atrial arrhythmias during DDD pacing by atrial overdrive. Pacing Clin Electrophysiol 1998;21:1751-9.
14. Murgatroyd FD, Nitzsche R, Slade AK, et al. A new pacing algorithm for overdrive suppression of atrial fibrillation. Chorus Multicentre Study Group. Pacing Clin Electrophysiol 1994;17:1966-73.
15. Ward KJ, Willett JE, Bucknall WC, Gill JS, Kamalvand K. Atrial arrhythmia suppression by atrial overdrive pacing: pacemaker Holter assessment. Europace 2001;3:108-14.
16. Lam CTF, Lau CP, Tse HF, Lee KLF, Tang MO, Tsang V. Efficacy and tolerability of continuous overdrive atrial pacing in atrial fibrillation. Europace 2000;2:286-91.
17. Levy T, Walker S, Rex S, Paul V. Does atrial overdrive pacing prevent paroxysmal atrial fibrillation in paced patients? Int J Cardiol 2000;75:91-7.
18. Ricci R, Santini M, Puglisi A, et al. Impact of consistent atrial pacing algorithm on premature atrial complex number and paroxysmal atrial fibrillation recurrences in brady-tachy syndrome: a randomized prospective cross over study. J Interv Card Electrophysiol 2001;5:33-44.
19. Funck RC, Adamec R, Lurje L, et al. Atrial overdriving is beneficial in patients with atrial arrhythmias: first results of the PROVE study. Pacing Clin Electrophysiol 2000;23:1891-3.
20. Zimetbaum PJ, Josephson ME. The evolving role of ambulatory arrhythmia monitoring in general clinical practice. Ann Intern Med 1999;130:848-56.
21. Kinlay S, Leitch JW, Neil A, Chapman BL, Hardy DB, Fletcher PJ. Cardiac event recorders yield more diagnoses and are more cost-effective than 48-hour Holter monitoring in patients with palpitations: a controlled clinical trial. Ann Intern Med 1996;124:16-20.